114 related articles for article (PubMed ID: 20636282)
1. Tissue-type plasminogen activator induces plasmin-dependent proteolysis of intracellular neuronal nitric oxide synthase.
Baron A; Hommet Y; Cassé F; Vivien D
Biol Cell; 2010 Aug; 102(10):539-47. PubMed ID: 20636282
[TBL] [Abstract][Full Text] [Related]
2. Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-kappaB pathway activation.
Zhang X; Polavarapu R; She H; Mao Z; Yepes M
Am J Pathol; 2007 Oct; 171(4):1281-90. PubMed ID: 17717150
[TBL] [Abstract][Full Text] [Related]
3. Key role of tissue plasminogen activator in neurovascular coupling.
Park L; Gallo EF; Anrather J; Wang G; Norris EH; Paul J; Strickland S; Iadecola C
Proc Natl Acad Sci U S A; 2008 Jan; 105(3):1073-8. PubMed ID: 18195371
[TBL] [Abstract][Full Text] [Related]
4. Tissue-type plasminogen activator neutralizes LPS but not protease-activated receptor-mediated inflammatory responses to plasmin.
Zalfa C; Azmoon P; Mantuano E; Gonias SL
J Leukoc Biol; 2019 Apr; 105(4):729-740. PubMed ID: 30690783
[TBL] [Abstract][Full Text] [Related]
5. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
Bi Oh S; Suh N; Kim I; Lee JY
Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
[TBL] [Abstract][Full Text] [Related]
6. Involvement of tissue plasminogen activator-plasmin system in depolarization-evoked dopamine release in the nucleus accumbens of mice.
Ito M; Nagai T; Kamei H; Nakamichi N; Nabeshima T; Takuma K; Yamada K
Mol Pharmacol; 2006 Nov; 70(5):1720-5. PubMed ID: 16908600
[TBL] [Abstract][Full Text] [Related]
7. Tissue type plasminogen activator facilitates NMDA-receptor-mediated retinal apoptosis through an independent fibrinolytic cascade.
Kumada M; Niwa M; Hara A; Matsuno H; Mori H; Ueshima S; Matsuo O; Yamamoto T; Kozawa O
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1504-7. PubMed ID: 15790922
[TBL] [Abstract][Full Text] [Related]
8. Fibrinolytic and Non-fibrinolytic Roles of Tissue-type Plasminogen Activator in the Ischemic Brain.
Yepes M
Neuroscience; 2024 Mar; 542():69-80. PubMed ID: 37574107
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: potential receptor interactions.
Lobov S; Croucher DR; Saunders DN; Ranson M
Thromb Haemost; 2008 Aug; 100(2):319-29. PubMed ID: 18690354
[TBL] [Abstract][Full Text] [Related]
10. Neuroserpin protects neurons from ischemia-induced plasmin-mediated cell death independently of tissue-type plasminogen activator inhibition.
Wu J; Echeverry R; Guzman J; Yepes M
Am J Pathol; 2010 Nov; 177(5):2576-84. PubMed ID: 20864675
[TBL] [Abstract][Full Text] [Related]
11. Tissue plasminogen activator protects hippocampal neurons from oxygen-glucose deprivation injury.
Flavin MP; Zhao G
J Neurosci Res; 2001 Mar; 63(5):388-94. PubMed ID: 11223913
[TBL] [Abstract][Full Text] [Related]
12. Tissue-type plasminogen activator-binding RNA aptamers inhibiting low-density lipoprotein receptor family-mediated internalisation.
Bjerregaard N; Bøtkjær KA; Helsen N; Andreasen PA; Dupont DM
Thromb Haemost; 2015 Jul; 114(1):139-49. PubMed ID: 25855589
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide mediates neurodegeneration and breakdown of the blood-brain barrier in tPA-dependent excitotoxic injury in mice.
Parathath SR; Parathath S; Tsirka SE
J Cell Sci; 2006 Jan; 119(Pt 2):339-49. PubMed ID: 16410551
[TBL] [Abstract][Full Text] [Related]
14. Tissue-type plasminogen activator controls neuronal death by raising surface dynamics of extrasynaptic NMDA receptors.
Lesept F; Chevilley A; Jezequel J; Ladépêche L; Macrez R; Aimable M; Lenoir S; Bertrand T; Rubrecht L; Galea P; Lebouvier L; Petersen KU; Hommet Y; Maubert E; Ali C; Groc L; Vivien D
Cell Death Dis; 2016 Nov; 7(11):e2466. PubMed ID: 27831563
[TBL] [Abstract][Full Text] [Related]
15. Proteolysis of neuronal cell adhesion molecule by the tissue plasminogen activator-plasmin system after kainate injection in the mouse hippocampus.
Endo A; Nagai N; Urano T; Takada Y; Hashimoto K; Takada A
Neurosci Res; 1999 Jan; 33(1):1-8. PubMed ID: 10096465
[TBL] [Abstract][Full Text] [Related]
16. Modification by the tissue plasminogen activator-plasmin system of morphine-induced dopamine release and hyperlocomotion, but not anti-nociceptive effect in mice.
Nagai T; Kamei H; Ito M; Hashimoto K; Takuma K; Nabeshima T; Yamada K
J Neurochem; 2005 Jun; 93(5):1272-9. PubMed ID: 15948318
[TBL] [Abstract][Full Text] [Related]
17. HMGB-1 promotes fibrinolysis and reduces neurotoxicity mediated by tissue plasminogen activator.
Roussel BD; Mysiorek C; Rouhiainen A; Jullienne A; Parcq J; Hommet Y; Culot M; Berezowski V; Cecchelli R; Rauvala H; Vivien D; Ali C
J Cell Sci; 2011 Jun; 124(Pt 12):2070-6. PubMed ID: 21610098
[TBL] [Abstract][Full Text] [Related]
18. Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function.
Samson AL; Nevin ST; Croucher D; Niego B; Daniel PB; Weiss TW; Moreno E; Monard D; Lawrence DA; Medcalf RL
J Neurochem; 2008 Nov; 107(4):1091-101. PubMed ID: 18796005
[TBL] [Abstract][Full Text] [Related]
19. Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus.
Echeverry R; Wu J; Haile WB; Guzman J; Yepes M
J Clin Invest; 2010 Jun; 120(6):2194-205. PubMed ID: 20440070
[TBL] [Abstract][Full Text] [Related]
20. Exogenous t-PA administration increases hippocampal mature BDNF levels. plasmin- or NMDA-dependent mechanism?
Rodier M; Prigent-Tessier A; Béjot Y; Jacquin A; Mossiat C; Marie C; Garnier P
PLoS One; 2014; 9(3):e92416. PubMed ID: 24670989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
